{"result": "{\n    \"title\": \"Septic Shock Treatment and Research Community\",\n    \"summary\": \"This community encompasses entities involved in the development, evaluation, and funding of treatments for septic shock, focusing on the rise and fall of drotrecogin alfa (activated) and the evaluation of hydrocortisone-plus-fludrocortisone. Key entities include Drotrecogin Alfa (Activated), Xigris, the APROCCHSS trial, and the French Ministry of Social Affairs and Health, highlighting the interconnected nature of medical research, regulatory decisions, and clinical trials.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant implications of these entities' activities on septic shock treatment guidelines and patient outcomes.\",\n    \"findings\": [\n        {\n            \"summary\": \"The rise and fall of Drotrecogin Alfa (Activated) and Xigris\",\n            \"explanation\": \"Drotrecogin Alfa (Activated) and its commercial form, Xigris, were initially hailed as promising treatments for septic shock, a critical condition with high mortality rates. However, their withdrawal from the market in 2011 due to failed subsequent trials to confirm survival benefits marks a significant event in the medical community's approach to septic shock treatment. This shift underscores the challenges in developing effective therapies for complex conditions and the importance of rigorous, ongoing clinical evaluation. [Data: Entities (52, 55), Relationships (11, 91, 92, 96)]\"\n        },\n        {\n            \"summary\": \"Impact of the APROCCHSS trial on septic shock treatment\",\n            \"explanation\": \"The APROCCHSS trial, which evaluated the effectiveness of hydrocortisone-plus-fludrocortisone therapy in septic shock patients, represents a pivotal moment in the search for viable treatments. Funded by the French Ministry of Social Affairs and Health and the Programme Hospitalier de Recherche Clinique 2007, this trial's findings contributed to a better understanding of septic shock management and highlighted the potential of combining treatments to improve patient outcomes. The trial's design and funding sources illustrate the collaborative effort required to advance medical research and treatment strategies. [Data: Entities (53, 54, 56), Relationships (89, 94, 95)]\"\n        },\n        {\n            \"summary\": \"The regulatory and clinical landscape post-Xigris withdrawal\",\n            \"explanation\": \"The withdrawal of Xigris from the market not only marked the end of its use but also prompted a reassessment of treatment protocols for septic shock. This event highlights the dynamic nature of the medical field, where treatments can be reevaluated as new evidence emerges. It underscores the importance of post-market surveillance and the impact of regulatory decisions on clinical practices and patient care. [Data: Entities (52, 55), Relationships (91, 93, 96)]\"\n        },\n        {\n            \"summary\": \"The role of funding bodies in clinical trials\",\n            \"explanation\": \"The involvement of the French Ministry of Social Affairs and Health and the Programme Hospitalier de Recherche Clinique 2007 as funding bodies for the APROCCHSS trial underscores the critical role of governmental and institutional support in advancing medical research. Funding decisions can significantly influence the scope, direction, and potential impact of clinical trials, highlighting the interconnectedness of research funding, public health policy, and treatment innovation. [Data: Entities (54, 56), Relationships (94, 95)]\"\n        },\n        {\n            \"summary\": \"Evaluating the effectiveness of hydrocortisone-plus-fludrocortisone\",\n            \"explanation\": \"The evaluation of hydrocortisone-plus-fludrocortisone in the APROCCHSS trial and its demonstrated reduction in 90-day all-cause mortality compared to placebo represents a forward step in septic shock treatment research. This insight into the trial's outcomes provides a basis for further investigation and potential integration into treatment guidelines, reflecting the ongoing quest for effective septic shock therapies. [Data: Entities (51, 53), Relationships (10, 89)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n52,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) was a medication specifically used in the treatment of septic shock. Initially, it was considered a promising therapy and was tested in various trials, including the APROCCHSS trial, which explored its interaction with corticosteroids in the management of septic shock. Despite its early use, drotrecogin alfa (activated) was withdrawn from the market in 2011. This decision was made after subsequent trials failed to confirm its survival benefit for patients, leading to a reassessment of its efficacy and relevance in septic shock treatment. Consequently, its significance in the medical community diminished following its market withdrawal, marking the end of its use as a treatment method for septic shock.\",5\n51,HYDROCORTISONE-PLUS-FLUDROCORTISONE,\"A therapy evaluated in a clinical trial for its effectiveness in treating septic shock, showing a reduction in 90-day all-cause mortality compared to placebo\",2\n55,XIGRIS,\"Xigris, the brand name for drotrecogin alfa (activated), was a drug used in the treatment of septic shock. It was the commercial form of drotrecogin alfa (activated) available on the market. However, Xigris was withdrawn from the market in October 2011. This withdrawal was due to concerns over its efficacy and safety, leading to its discontinuation. The decision to withdraw Xigris was consistent across all descriptions, highlighting its removal from the market in 2011 after being identified as a treatment option for septic shock.\",2\n53,APROCCHSS,The clinical trial named Activated Protein C and Corticosteroids for Human Septic Shock that evaluated the effect of hydrocortisone-plus-fludrocortisone therapy on septic shock patients,4\n54,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The funding body for the APROCCHSS clinical trial through Programme Hospitalier de Recherche Clinique 2007,1\n56,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n11,SEPTIC SHOCK,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) was initially used in the treatment of septic shock before it was withdrawn from the market. This medication was specifically aimed at managing septic shock, a severe condition, but due to various reasons, it is no longer available for this purpose.\",21\n10,SEPTIC SHOCK,HYDROCORTISONE-PLUS-FLUDROCORTISONE,\"The therapy was evaluated for its effectiveness in treating septic shock, showing a reduction in mortality\",18\n92,DROTRECOGIN ALFA (ACTIVATED),APROCCHSS TRIAL,Drotrecogin alfa (activated) was one of the treatments tested in the APROCCHSS trial for septic shock,14\n93,DROTRECOGIN ALFA (ACTIVATED),HYDROCORTISONE PLUS FLUDROCORTISONE,The potential interaction between drotrecogin alfa (activated) and hydrocortisone plus fludrocortisone was not assessed due to the withdrawal of Xigris from the market,11\n96,XIGRIS,APROCCHSS TRIAL,The trial continued with two parallel groups after Xigris was withdrawn from the market,11\n90,DROTRECOGIN ALFA (ACTIVATED),APROCCHSS,The APROCCHSS trial was designed to evaluate drotrecogin alfa (activated) among other therapies for septic shock before its withdrawal,9\n91,DROTRECOGIN ALFA (ACTIVATED),XIGRIS,\"Drotrecogin alfa (activated), also known as Xigris, is a medication that was available under the brand name Xigris. It was withdrawn from the market in 2011. Xigris served as the commercial form of drotrecogin alfa (activated), indicating that both names refer to the same product. The withdrawal applies universally to the product, regardless of the name it was marketed under.\",7\n89,HYDROCORTISONE-PLUS-FLUDROCORTISONE,APROCCHSS,The APROCCHSS trial evaluated the effectiveness of hydrocortisone-plus-fludrocortisone therapy in septic shock,6\n94,APROCCHSS,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The APROCCHSS trial was funded by the French Ministry of Social Affairs and Health,5\n95,APROCCHSS,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,The program funded the APROCCHSS clinical trial,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}